Italian Medicines Agency Agenzia Italiana del Farmaco

Direct communication with healthcare professionals on Spikevax bivalent booster vaccines - Direct communication with healthcare professionals on Spikevax bivalent booster vaccines

Asset Publisher

Asset Publisher

Direct communication with healthcare professionals on Spikevax bivalent booster vaccines

The Italian Medicines Agency would like to inform you of the following:

Reports of accidental underdosing of the Spikevax bivalent booster vaccines have been reported, where a 0.25 mL dose (equivalent to 25 µg) was administered instead of 0.5 mL (50 µg). In most cases, underdosing was due to dose confusion, since the booster dose volume for the original monovalent Spikevax vaccine used earlier in 2022 was 0.25 mL (equivalent to 50 µg). 

  • Spikevax bivalent booster vaccines have recently been approved by EMA for use in individuals 12 years of age and older. The correct dose is 0.5 mL (50 µg).


Published on: 11 November 2022

Asset Publisher

Galleria

Cookie Bar

cookie management module

Descrizione cookieBar

Questo sito utilizza cookie tecnici e analytics, necessari al suo funzionamento, per i quali non è richiesto il consenso. Per alcuni servizi aggiuntivi, le terze parti fornitrici, dettagliatamente sotto individuate, possono utilizzare cookies tecnici, analytics e di profilazione. Per saperne di più consulta la PRIVACY POLICY. Per proseguire nella navigazione devi effettuare la scelta sui cookie di terze parti dei quali eventualmente accetti l’utilizzo. Chiudendo il banner attraverso la X in alto a destra rifiuti tutti i cookie di terze parti. Puoi rivedere e modificare le tue scelte in qualsiasi momento attraverso il link "Gestione cookie" presente nel footer.

Social networks
go to beginning of content